A four-layer solid phase enzyme-immunoassay (EIA) and radioimmunoassay (RIA) techniques were applied for the type-specific detection of parainfluenza type 1, 2 and 3 virus antigens in sonicated nasopharyngeal specimens of patients with acute respiratory disease. Guinea-pig antiviral immunoglobulins on solid phase were used as the capture antibodies, rabbit antiviral immunoglobulins as the secondary antibodies, and horseradish peroxidase-labelled swine anti-rabbit immunoglobulins (EIA), or x25I-labelled sheep anti-rabbit IgG (RIA) as the indicator antibodies. A total of 174 nasopharyngeal specimens collected by mucus extractor were tested, and the results were compared with those obtained by a routinely used immunofluorescence (IF) technique. The same number of positive specimens were achieved by the EIA and the RIA and 3/4, 4/4 and 19/20 immunofluorescence (IF)-positive nasopharyngeal specimens were positive by the parainfluenza type 1, 2 and 3 immunoassays respectively. In addition, four parainfluenza type 1 and three parainfluenza type 3 virus-positive specimens were found by the immunoassays out of 146 parainfluenza IF-negative specimens. The type-specificities of the parainfluenza immunoassays were confirmed by showing that no cross-reactions occurred when purified immunizing antigens and the EIA-and RIA-positive clinical specimens were cross-tested. The results indicate that parainfluenza type-specific antigens can be detected directly in nasopharyngeal specimens by the immunoassays and the preliminary findings with a small number of positive specimens suggest that these assays have a diagnostic potential which is similar or slightly better than the IF techniques.
INTRODUCTION
The parainfluenza virus types 1, 2, 3, 4a and 4b cause upper and lower respiratory tract infections in children. The diagnosis of the diseases caused by the parainfluenza viruses is usually done by virus isolation in cell cultures and typing the virus by neutralization, or by demonstrating a significant seroconversion in paired serum specimens. All these methods are, however, time consuming and a rapid and specific diagnosis cannot be made at the acute stage of the disease. Furthermore, the serological diagnosis is of limited value in establishing a rapid diagnosis since cross-reactions are known to occur between paramyxoviruses (Chanock diagnosis of respiratory infections. The use of IF as a diagnostic method, however, requires a skilled microscopist and is difficult to automatize. Solid-phase enzyme-immunoassay (EIA) and radioimmunoassay (RIA) methods offer an alternative way of detecting viral antigens from clinical specimens and have been applied with great success in the detection of gastroenteritis viruses (Yolken et al., 1977; Sarkkinen et al., 1979; Halonen et al., 1980) and hepatitis A and B viruses (Purcell et al., 1973; Mathiesen et al., 1978) . The recent work done in our laboratory (Sarkkinen et al., 1981 a, b) and in other laboratories (Chao et al., 1979; Berg et al., 1980) has indicated that the solid-phase immunoassays can be applied also in the detection of respiratory viruses as well. In the present study solid-phase EIA and RIA methods were applied for the detection of parainfluenza type 1, 2 and 3 virus antigens. The details of the techniques are described and the preliminary findings of the use of the methods in the type-specific diagnosis of respiratory infections caused by the parainfluenza type 1, 2 and 3 viruses, are presented.
METHODS
Specimens. The nasopharyngeal specimens were obtained from 174 patients hospitalized with acute respiratory disease in Turku University Hospital and Turku City Hospital during the epidemics in 1978, 1979 and 1980 . The nasopharyngeal specimens were processed according to the technique of Gardner & McQuillin (1974) . Briefly, the specimens were diluted with 1 to 2 ml of sterile phosphate-buffered saline (PBS) pH 7.35, and the mucus was broken with a wide bore Pasteur pipette. The specimens were then centrifuged at 1000 rev/min for 10 min, and the supernatant containing the soluble viral antigens (mucus fraction) and the pellet containing the cells were collected. The cells were further suspended in PBS pH 7-35, the remaining unbroken mucus was removed with a Pasteur pipette, and the cells were recentrifuged at 1000 rev/min for 10 min at 4 °C. The washed cells were then diluted with PBS pH 7.35 to obtain optimum cell concentration, and slide preparations were made for IF studies. The mucus fractions and, from those specimens with sufficient volumes, part of the original nasopharyngeal specimens, without further processing, were stored at -70 °C for RIA and EIA studies. Before testing by RIA and EIA, the specimens (original nasopharyngeal specimens, and mucus fractions) were diluted 1/2.5 in PBS, containing 20 % inactivated foetal calf serum, 2 % Tween 20 and 10 -4 merthiolate and sonicated for 1 to 3 min with a Branson Sonifier Cell Disruptor B15 to solubilize the mucus and to homogenize the specimens. The specimens were then further diluted in the same buffer, and tested in 1/20 dilution of the original nasopharyngeal specimens, and 1/5 dilutions of the mucus fractions. However, the actual dilution of the mucus fractions was higher than 1/5 and varied considerably because of the original dilution in PBS as indicated above.
Propagation of parainfluenza type 1, 2 and 3 viruses. Egg-grown parainfluenza type 1 virus (Sendal, HA titre 1:6000) concentrate was kindly provided by Professor K. Cantell (Central Public Health Laboratory, Helsinki, Finland). Parainfluenza type 2 and 3 viruses were grown in roller cultures of Vero cells at + 35 ° C. Basic medium Eagle (BME) with 0.2 % bovine serum albumin (Armour Pharmaceutical, Eastbourne, U.K.), 5% (v/v) tryptose phosphate (Difco) and antibiotics, was used as the maintenance medium. When the cells showed an extensive cytopathic effect, usually in 5 or 6 days, the cells of parainfluenza type 2 virus-infected cultures and the supernatant of parainfluenza type 3 virus-infected cultures were collected and processed further.
Purification ofparainfluenza type 3 virions. The supernatant of the parainfluenza type 3-infected cells was centrifuged for 20 min at 8000 rev/min and concentrated further 20-fold by Amicon Hollow Fiber Dialyser/Concentrator. The concentrated virus preparation was purified by two subsequent potassium tartrate gradient centrifugations as follows. The virus materials were centrifuged in a Spinco SW27 rotor at 25 000 rev/min for 90 min on potassium tartrate step gradients (10 ml 18% and 3 ml 36% potassium tartrate), followed by a second centrifugation in the same rotor on linear potassium tartrate gradients (11 m136 %, and 12 ml 18 % potassium tartrate) for 180 min at 25 000 rev/min. The purified virus was then dialysed overnight in PBS pH 7.35, pelleted in a Spinco SW27 rotor at 25 000 rev/min for 45 rain, and resuspended in PBS. The protein content of the purified virions, determined according to Lowry et al. (1951) , was 3 mg/ml.
Purification of parainfluenza type I and 2 nucleocapsids. Parainfluenza type 1 virions were purified from the allantoic fluid of infected eggs as indicated above for parainfluenza type 3 virions. Deoxycholate in a final concentration of 0.25 % was then added to the purified virus preparation followed by incubation for 1 h at room temperature with constant stirring. The deoxycholate-treated virus material was centrifuged in a Spinco SW27 rotor for 25 000 rev/min for 3 h at +4 °C on CsCI step gradients (3 ml 25%, 2 ml 30%, 1 ml 40% CsC1) followed by recentrifugation on second CsC1 step gradients (20%, 25 %, 30%, 35 % and 40% CsC1, 1.2 ml each) overnight in the same rotor for 25000 rev/min. The virus material banding in 30% CsCI was then collected and dialysed overnight against PBS pH 7.35. The protein content of the final preparation was 2.3 mg/ml of the purified nucleocapsid material. The purification of parainfluenza type 2 nucleocapsid from the virus-infected cells was done as reported elsewhere (Sarkkinen et aL, 1981a) . Briefly, the virus-infected cells were homogenized in a Sorvall Omnimixer at full velocity for 2 min on ice. After the homogenization, 1% trypsin (Difco) was added to give a final concentration of 0.25 % (w/v) and the cell suspension was incubated at room temperature for 60 min with constant stirring followed by centrifugation for 20 min at 2000 rev/min. The supernatant fraction was then centrifuged on CsCI step gradients as indicated above for parainfluenza type 1 virus, and the nucleocapsid band at the 30% CsC1 layer was collected and dialysed overnight against PBS pH 7.35. A final concentration of 0.05 % (w/v) of trypsin was then added to the nucleocapsid solution, and the mixture was incubated at room temperature for 30 min with constant stirring. The trypsin-treated nucleocapsid material was then recentrifuged into 30% CsCI as indicated above and layered on a third CsCI step gradient (20%, 25 %, 30%, 35 % and 40% CsC1, 1.2 ml each) and centrifuged overnight at 25 000 rev/min at 4 °C in a SW27 rotor. The purified nucleocapsid preparation was concentrated by centrifugation at 25 000 rev/min at 4 °C in a Spinco SW27 rotor, and the pellet was collected. The protein content of the purified preparation was 1-7 mg/ml.
Immunizations and preparation of viral immunoreagents. Rabbit anti-parainfluenza type 1 nucleocapsid and anti-parainfluenza type 3 virion hyperimmune sera were prepared by immunizing intradermally two rabbits with 300 #g/animal of purified virus protein in PBS mixed with an equal amount of incomplete Freund's adjuvant. Intradermal boosters (200 #g/animal) were given 3 and 6 weeks after the first injection. One week after the final injection, the animals were exsanguinated and the sera pooled and preserved at -70 °C. Five guinea-pigs were immunized in a similar way except that 100 #g of antigens was used in each immunization. The guinea-pig sera were pooled and preserved as above. The immunization procedure for the preparation of parainfluenza type 2 nucleocapsid hyperimmune sera in rabbits and guinea-pigs is identical to the procedure indicated above and has been described elsewhere (Sarkkinen et al., 1981) . The preparation of guinea-pig and rabbit immunoglobulin fractions from the hyperimmune sera were done as described for adenovirus (Halonen et al., 1980) .
EIA for parainfluenza type 1, 2 and 3, and mumps antibodies. The guinea-pig and rabbit anti-parainfluenza type 1, 2 and 3, and anti-mumps antibody titres of the parainfluenza hyperimmune sera were determined by EIA modified from RIA .
RIA for parainfluenza type 1, 2 and 3 viral antigens. Polystyrene beads (6-4 mm in diam., Precision Plastic Ball Co., Chicago, Ill., U.S.A.) were coated with anti-parainfluenza type 1, 2 or 3 guinea-pig immunoglobulin by incubating the untreated beads overnight in an antibody solution containing 1.25 #g anti-parainfluenza type l, 2 or 3 immunoglobulin/ml (0.25 #g/bead). Carbonate buffer pH 9.6 was used as the diluent (Voller, 1976) . Beads were stored in these antibody solutions at 4 °C until used, usually not more than for 2 weeks. Nasopharyngeal specimens in 200-#1 vol. in a single (v/v) dilution or serially diluted were pipetted into disposable polystyrene tubes and a polystyrene bead with adsorbed antiviral immunoglobulin was then added to each tube. After overnight incubation at 37 °C, the specimens were aspirated and the beads were washed twice with 5 ml of tap water. A 200 #1 vol. of rabbit anti-parainfluenza type 1, or 2 immunoglobulins (4 #g/ml) or anti-parainfluenza type 3 immunoglobulin (8 #g/ml) was then added to each tube and the beads were incubated at 37 °C for 1 h. The beads were washed as described above and 200 #1 12~I-labelled sheep anti-rabbit immunoglobulin was added to each tube, and the beads were incubated for an additional hour at 37 °C. After the washing, the beads were placed in clean tubes and counted in a LKB 1280 gamma counter. Buffer blanks and titrations of purified immunizing antigens used as positive controls were included in each assay. As a dilution buffer, PBS pH 7.35, containing 20 % inactivated foetal calf serum (Gibco), 2 % Tween 20, and 0.1% NaN 3, was used in all steps. The assay was standardized by diluting the iodinated anti-rabbit immunoglobulins to a concentration that gave 5000 ct/min bound (5000 active ct/min), when 200 #1 of the label was incubated with a bead adsorbed with 2 #g purified rabbit IgG. Twice the mean of the ct/min values for the negative specimens was taken as the cut-off value. This was usually between 200 and 300 ct/min and specimens with a higher ct/min value were considered as positive provided that confirmatory tests indicated specific binding.
EIA for parainfluenza type 1, 2 and 3 virus antigens. The EIAs for parainfluenza type 1, 2 and 3 antigens and the confirmatory tests are identical to the corresponding RIA methods. The same incubation times and the same concentrations of the reagents were used. The tests were done as follows: polystyrene flat bottom microtitre plates (no. 76-201-05, Flow Laboratories) were used as the solid phase instead of polystyrene beads because the colour reactions could be measured directly through the bottoms of the microtitre plate wells. The plates were coated with 100 #1 of either 0.0625 #g of the anti-parainfluenza type 1 virus, or 0.25 #g of anti-parainfluenza type 2 and 3 virus immunoglobulins/well. 100 #1 of the specimen dilutions were pipetted into each of the wells, incubated overnight at 37 °C, followed by washing twice with PBS containing 0.1% Tween 20, and the subsequent addition of a 100 #l/well of the appropriate rabbit antiviral immunoglobulins. After 1 h incubation at 37 °C and the washing, 100 #1/well of horseradish peroxidase-conjugated swine antibodies against rabbit immunoglobulins (Orion Diagnostica, Helsinki, Finland) in a dilution of 1:2000 was added. After an additional 1 h incubation at 37 °C and washing, 100 #1 of the substrate solution, consisting of 3 mg/ml of orthophenylene diamine (OPDA, Koch-Light Laboratories, Colnbrook, Bucks., U.K.) in 0.1 M-citrate-Na2HPO4 buffer pH 5-5 and 10/~1 30% H202 per 15 ml in the same buffer, was added to each of the wells. The reaction was stopped by adding I00 #1 1 M-HC1 after incubation for 1 h at room temperature in the dark. The intensity of the colour at 492 nm was determined with a Titertek Multiscan spectrophotometer (Flow Laboratories). As a diluent, PBS pH 7.35, containing 20% inactivated foetal calf serum, 2% Tween 20 and 10 -4 M-merthiolate was used in all steps, except for the substrate solution. The assay was standardized by selecting a dilution of the enzyme conjugated anti-rabbit immunoglobulins that gave the maximum sensitivity and lowest background values when purified immunizing antigens were tested in the assay proper against serial dilutions of the enzyme conjugate. Twice the mean of the absorbance values of the negative specimens was taken as the cut-off value. This was usually between 0.1 and 0.2 and the specimens with a higher absorbance value were considered positive provided that the confirmatory tests indicated specific binding.
RIA and EIA confirmatory tests for parainfluenza type 1, 2 and 3 antigens.
To test the specificity of the binding, blocking tests were performed on selected specimens. The tests were done in the same way as described above except that the anti-parainfluenza type 1, 2 or 3 guinea-pig serum, preimmune serum or dilution buffer was added before the secondary rabbit antibody. The tests were considered positive if a 50% or greater decrease in absorbance values or ct/min values was noticed with the wells or beads incubated with guinea-pig hyperimmune sera, as compared to wells or beads incubated with normal guinea-pig sera or dilution buffer.
EIA and RIA for respiratory syncytial virus, adenovirus, and influenza A and B virus antigens. The methods have been reported in detail elsewhere (Sarkkinen et al., 1981 a, b) .
Immunofluorescence (IF) . A standard indirect immunofluorescence method was used for the detection of parainfluenza type 1, 2 and 3 virus antigens in the cells of the nasopharyngeal secretions of patients with acute respiratory disease (Gardner & McQuillin, 1974) . A rabbit anti-parainfluenza type 1 (kindly supplied by Dr Monica Grandien, State Bacteriological Laboratory, Stockholm, Sweden), a guinea-pig anti-parainfluenza type 2 (kindly supplied by G. /kstad, Statens Institut for Folkenhelse, National Institute of Public Health, Oslo, Norway), and a bovine anti-parainfluenza type 3 (WeUcome Research Laboratories) sera were used. The detection of respiratory syncytial virus, adenovirus and influenza A virus antigens by indirect immunofluorescence has been reported elsewhere (Sarkkinen et aL, 1981 a, b) .
RESULTS
The guinea-pig and rabbit parainfluenza type 1, 2 and 3 hyperimmune sera were studied for the presence of homologous and heterologous antibodies by EIA with parainfluenza type 1, 2 and 3 viruses and mumps virus as antigens. The results are presented in Table 1 and they indicate that while the homologous antibody titres of hyperimmune guinea-pig and rabbit antisera were very high, varying from 1/500000 to 1/10000000, some low titred heterologous cross-reactivities were found.
Immunoglobulin fractions were prepared from the unabsorbed guinea-pig and rabbit parainfluenza type 1, 2 and 3 hyperimmune sera and optimum concentrations for the primary guinea-pig and for the secondary rabbit antibodies were determined by the box EIA and RIA titrations. This was done by testing serial dilutions of purified immunizing antigens against increasing amounts of primary guinea-pig and secondary rabbit immunoglobulins. The combinations of guinea-pig and rabbit immunoglobulins with the highest sensitivity, determined as ng/ml of purified immunizing antigens, were selected. Comparison of the sensitivities of parainfluenza type 1, 2 and 3 EIAs and RIAs for the corresponding homologous immunizing antigens are indicated in Table 2 . The sensitivity of each parainfluenza antigen assay, either EIA or RIA, was approximately the same varying between 1 and 10 ng/ml for parainfluenza type 1 and 3 assays and between 10 and 30 ng/ml for parainfluenza type 2 assays.
The type specificities of parainfluenza type 1, 2 and 3 immunoassays for parainfluenza virus antigens were studied by cross-testing the purified immunizing antigens and all the EIA/RIA-positive nasopharyngeal specimens in EIA. Representative results of the tests are indicated in Table 3 . No cross-reactions between the parainfluenza antigen assays were found whether the purified immunizing antigens or nasopharyngeal specimens were tested. As a further control, purified adenovirus type 2 hexon, influenza A and B virus, respiratory syncytial virus, and mumps cell lysate antigens, and one nasopharyngeal specimen, strongly positive for adenovirus, influenza A virus, or respiratory syncytial virus, were tested in each parainfluenza test with negative results. Parainfluenza 1 Guinea-pig 10000000" <1000 10000 <1000 Rabbit 10 000 000 < 1000 10 000 < 1000
Parainfluenza 2 Guinea-pig < 1000 1000000 < 1000 5000 Rabbit < 1000 500 000 < 1000 1000
Parainfluenza 3 Guinea-pig 50000 <1000 1000000 <1000 Rabbit 10 000 < 1000 500 000 < 1000 * Reciprocal titre. * Twice the mean of the three buffer blanks (0 ng/ml) was taken as the cut-off line in each test. ~" Absorbance at 492 nm. $ Ct/min. * Three specimens, strongly positive for one of the three viruses were tested at 1/5 dilution. ~" Absorbance at 492 nm.
Limited numbers of parainfluenza IF-positive clinical specimens were available for testing in parainfluenza immunoassays. The EIA and the RIA results were identical, and 3/4 of the parainfluenza type 1, 4/4 of the parainfluenza type 2, and 19/20 of the parainfluenza type 3 IF-positive specimens were positive in parainfluenza type 1, 2 and 3 immunoassays respectively. Furthermore, four additional specimens were positive in parainfluenza type 1 immunoassays, and three in parainfluenza type 3 immunoassays of the 146 parainfluenza IF-negative specimens (negative also for adenovirus, influenza A and B, and respiratory syncytial virus antigens by IF and RIA and/or EIA) (Table 4) . * The binding was considered specific if a 50 % or greater decrease in absorbance values was observed in wells incubated with guinea-pig anti-parainfluenza type 1, or 3 hyperimmune serum as compared to well incubated with preimmune guinea-pig serum and with dilution buffer. The percentage values presented as the specific blocking were calculated as compared to the dilution buffer.
~" Absorbance measured at 492 nm.
To test the specificity of the binding in immunoassays, each specimen with contradictory results between IF and immunoassays and selected IF and EIA/RIA-positive specimens were studied in the blocking tests. The specificity of the binding was proved in each case tested. Table 5 represents the results of the parainfluenza type 1 and 3 EIA confirmatory tests for four specimens with negative IF result but positive result in immunoassays.
DISCUSSION
The potential of highly sensitive immunoassays for the detection of viral antigens in the diagnosis of viral infections has been proved in hepatitis B and viral gastroenteritis. This experience has increased the hope of applying the same technology to the rapid diagnosis of viral respiratory infections as well. In the present study, the principles of indirect immunoassays (four-layer immunoassays), previously described for the detection of adenovirus, influenza A and B, parainfluenza type 2, and respiratory syncytial virus antigens, were applied for the type-specific detection of parainfluenza virus antigens directly in nasopharyngeal specimens.
The material included in this study consisted mostly of stored mucus fractions of the nasopharyngeal specimens collected as by-products when slide preparations were made for IF studies. Our previous studies with respiratory syncytial virus (Sarkkinen et aL, 1981 a) , however, indicated that the original, undiluted nasopharyngeal secretions collected by suction from the nasopharynx with a mucus extractor, should be used as specimens instead of the mucus fractions or throat washings (Berg et aL, 1980) . This conclusion was based on the fact that several respiratory syncytial virus IF-positive specimens were found negative or borderline positive from the mucus fractions by immunoassays, but only one from the original nasopharyngeal specimens. These results indicated that the sensitivity of the immunoassays is not always enough for mucus fractions or throat washings but is sufficient for the original nasopharyngeal specimens representing a more concentrated specimen. It is likely that this is the reason why two specimens, positive in parainfluenza type 1 and 3 IF tests, were found negative by the immunoassays since only mucus fractions were available from these specimens, and the ~rue dilution of these specimens was not known. This conclusion was further supported by the finding that when both the original nasopharyngeal specimen and the corresponding mucus fraction was available from the immunoassaypositive specimens, the binding values were usually much higher with the original nasopharyngeal specimens.
It is well known that serological cross-reactions occur between the viruses of the paramyxovirus group (Chanock et al., 1960 , Lennette et al., 1963 , Penttinen & Cantell, 1967 and that guinea-pigs repeatedly infected with one type of paramyxovirus also produce heterologous antibodies to other paramyxoviruses (van der Veen & Sonderkamp, 1965) . This was also found in the present study, when the guinea-pig and rabbit hyperimmune sera, used as the primary and secondary antibodies, were studied for the presence of cross-reacting antibodies against parainfluenza and mumps viruses. Titres for heterologous antibodies, ranging from 1/1000 to 1/50000 were found in pooled guinea-pig and rabbit antisera. However, when immunoglobulin fractions of the unabsorbed hyperimmune sera, whether made against purified nucleocapsids (parainfluenza type 1 and 2) or purified virions (parainfluenza type 3), were used in the assays proper, only the homologous antigens were detected. The explanation for this may be that since very small amounts of immunoglobulins are required to coat the solid phase, and as the secondary antibodies, the concentration of heterologous antibodies is too low to cause any cross-reactions even with specimens with a fairly high concentration of antigen. Accordingly, it was unnecessary to absorb the hyperimmune sera with heterologous paramyxoviruses.
Immunofluorescence with antisera used among the members of the European Group of Rapid Viral Diagnosis, was used as the reference technique in the present study instead of virus isolation. This was considered justified since it has been shown by Gardner & McQuillin (1974) that the overall agreement between the immunofluorescence and virus isolation for parainfluenza viruses is more than 99 %. Furthermore, our own experience over several years with the use of the immunofluorescence as the routine diagnostic method for the detection of respiratory virus antigens has assured us of the specificity and sensitivity of the technique.
In spite of the fact that only a very limited number of parainfluenza virus-positive specimens were available for the present study and that more experience must be gained before final conclusions are made, the results strongly suggest that the indirect immunoassays are useful methods in the rapid diagnosis of parainfluenza infections. The results of the present and earlier studies (Sarkkinen et al., 1981 a, b) , and the results of other groups (Chao et al., 1979; Berg et aL, 1980) indicate that at least adenovirus, influenza A and B virus, parainfluenza types 1, 2 and 3, and respiratory syncytial virus antigens can be detected directly from the nasopharyngeal specimens of patients with acute respiratory infection.
The excellent technical assistance of Ms Kaija Johansson is gratefully acknowledged. This work was supported by the grants from the Sigrid Jtiselius, the Daisy and Yrj6 Eskola foundation, and Academy of Finland, Medical Research Council.
